Works matching IS 01145916 AND DT 2021 AND VI 44 AND IP 2


Results: 11
    1
    2
    3
    4
    5
    6

    Consensus Guidelines: Best Practices for Detection, Assessment and Management of Suspected Acute Drug-Induced Liver Injury During Clinical Trials in Adults with Chronic Viral Hepatitis and Adults with Cirrhosis Secondary to Hepatitis B, C and Nonalcoholic Steatohepatitis.

    Published in:
    2021
    By:
    • Treem, William R.;
    • Palmer, Melissa;
    • Lonjon-Domanec, Isabelle;
    • Seekins, Daniel;
    • Dimick-Santos, Lara;
    • Avigan, Mark I.;
    • Marcinak, John F.;
    • Dash, Ajit;
    • Regev, Arie;
    • Maller, Eric;
    • Patwardhan, Meenal;
    • Lewis, James H.;
    • Rockey, Don C.;
    • Di Bisceglie, Adrian M.;
    • Freston, James W.;
    • Andrade, Raul J.;
    • Chalasani, Naga
    Publication type:
    journal article
    8

    Adverse Drug Reaction Reporting Using a Mobile Device Application by Persons with Multiple Sclerosis: A Cluster Randomized Controlled Trial.

    Published in:
    Drug Safety, 2021, v. 44, n. 2, p. 223, doi. 10.1007/s40264-020-01009-z
    By:
    • Defer, Gilles;
    • Fedrizzi, Sophie;
    • Chevanne, Damien;
    • Montastruc, François;
    • Briant, Anais R.;
    • Parienti, Jean-Jacques;
    • Peyro-Saint-Paul, Laure;
    • for the French VigipSEP Study Group;
    • Defer, G.;
    • Derache, N.;
    • Branger, P.;
    • Casez, O.;
    • Vaillant, M.;
    • Labauge, P.;
    • Magy, L.;
    • Montcuquet, A.;
    • Castelnovo, G.;
    • Cohen, M.;
    • Bourre, B.;
    • Kwiatkowski, A.
    Publication type:
    Article
    9
    11